STTCOMP ANP FA Long
Antisense Therapeutics
Market Cap - around $55m
Biotech developing therapeutics for various conditions including Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly. They have just listed on the Frankfurt Stock Exchange. The share price has taken a hit recently as they have raised capital at 10c and currently have an open SPP at the same price which is due to close late this week. Prior to the capital raising, the SP was in a nice uptrend with recent catalysts being orphan drug designation. I'm going with the CR theory that shares around the issue price are a good entry price. Today, the share price ducked under 10c. Once the SPP is out of the way, I'm expecting the uptrend to continue. Plus they have a number of fronts on which they could release news.
- Forums
- ASX - Short Term Trading
- Short Term Trading Week Starting: 23 Nov
STTCOMP ANP FA LongAntisense TherapeuticsMarket Cap - around...
-
- There are more pages in this discussion • 86 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Featured News
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online